title: Modulation of TGF-β signaling by endoglin in murine hemangioblast development and primitive hematopoiesis.
abstract: Endoglin (Eng), an accessory receptor for the transforming growth factor β (TGF-β) superfamily, is required for proper hemangioblast and primitive hematopoietic development. However the mechanism by which endoglin functions at this early developmental stage is currently unknown. Transcriptional analyses of differentiating eng(-/-) and eng(+/+) ES cells revealed that lack of endoglin leads to profound reductions in the levels of key hematopoietic regulators, including Scl, Lmo2, and Gata2. We also detected lower levels of phosphorylated Smad1 (pSmad1), a downstream target signaling molecule associated with the TGF-β pathway. Using doxycycline-inducible ES cell lines, we interrogated the TGF-β signaling pathway by expressing activated forms of ALK-1 and ALK-5, type I receptors for TGF-β. Our results indicate that ALK-1 signaling promotes hemangioblast development and hematopoiesis, as evidenced by colony assays, gene expression and FACS analyses, whereas signaling by ALK-5 leads to the opposite effect, inhibition of hemangioblast and hematopoietic development. In Eng(-/-) ES cells, ALK-1 rescued both the defective hemangioblast development, and primitive erythropoiesis, indicating that ALK-1 signaling can compensate for the absence of endoglin. We propose that endoglin regulates primitive hematopoiesis by modulating the activity of the Smad1/5 signaling pathway in early stages of development.
authors: Department of Medicine, Lillehei Heart Institute, University of Minnesota, Minneapolis, MN, USA.
authors: Liying
authors: L
authors: Zhang
authors: Alessandro
authors: A
authors: Magli
authors: Jacquelyn
authors: J
authors: Catanese
authors: Zhaohui
authors: Z
authors: Xu
authors: Michael
authors: M
authors: Kyba
authors: Rita C R
authors: RC
authors: Perlingeiro
references: Blood. 2008 Dec 1;112(12):4512-22
references: 18805961
references: Development. 1993 Jun;118(2):489-98
references: 8223275
references: Development. 1995 Jun;121(6):1845-54
references: 7600998
references: Development. 1990 Apr;108(4):645-56
references: 1696875
references: Stem Cells Dev. 2009 Jun;18(5):783-92
references: 18808325
references: EMBO J. 2008 Oct 22;27(20):2766-79
references: 18833193
references: EMBO J. 2004 Oct 13;23(20):4018-28
references: 15385967
references: J Biol Chem. 1999 Jan 8;274(2):584-94
references: 9872992
references: J Pathol. 2011 Aug;224(4):461-72
references: 21465486
references: Cell. 1993 Nov 19;75(4):671-80
references: 8242742
references: Dev Dyn. 1997 Aug;209(4):418-30
references: 9264265
references: Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16806-11
references: 17077151
references: Blood. 2006 Dec 15;108(13):4018-24
references: 16926294
references: Cell Stem Cell. 2008 May 8;2(5):497-507
references: 18462699
references: EMBO J. 2001 Apr 2;20(7):1663-73
references: 11285230
references: Nature. 1987 Oct 8-14;329(6139):539-41
references: 2889143
references: Development. 2007 Aug;134(16):3041-8
references: 17634194
references: Dev Biol. 2000 Jan 1;217(1):42-53
references: 10625534
references: Genes Dev. 1996 Jul 1;10(13):1580-94
references: 8682290
references: J Clin Invest. 1999 Nov;104(10):1343-51
references: 10562296
references: Nat Genet. 1994 Dec;8(4):345-51
references: 7894484
references: Genes Dev. 1995 Sep 1;9(17):2105-16
references: 7657163
references: Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15468-73
references: 12438646
references: J Cell Sci. 2001 Apr;114(Pt 8):1483-9
references: 11282024
references: Cell. 1993 Nov 19;75(4):681-92
references: 8242743
references: Blood. 2004 Aug 1;104(3):711-8
references: 15090446
references: EMBO J. 2002 Apr 2;21(7):1743-53
references: 11927558
references: Blood. 2007 Mar 1;109(5):1953-61
references: 17068149
references: Dev Biol. 1996 Oct 10;179(1):297-302
references: 8873772
references: Dev Biol. 2006 Aug 1;296(1):104-18
references: 16765933
references: J Biol Chem. 1999 Apr 9;274(15):9984-92
references: 10187774
references: Development. 1998 Feb;125(4):725-32
references: 9435292
references: Lab Invest. 2009 Jul;89(7):800-10
references: 19398960
references: Leuk Lymphoma. 1995 Apr;17(3-4):229-44
references: 8580791
references: J Biol Chem. 1992 Sep 25;267(27):19027-30
references: 1326540
references: Blood. 1995 Jan 1;85(1):96-105
references: 7528578
references: Development. 2004 Jun;131(11):2749-62
references: 15148304
references: Nature. 2004 Dec 2;432(7017):625-30
references: 15577911
references: Cell Stem Cell. 2008 Jan 10;2(1):60-71
references: 18371422
references: J Biol Chem. 2006 Sep 1;281(35):25110-23
references: 16785228
references: Dev Biol. 2003 Sep 1;261(1):235-50
references: 12941632
references: Blood. 2007 Jan 15;109(2):516-23
references: 16990609
references: Blood. 2001 Dec 15;98(13):3635-42
references: 11739167
references: Stem Cells. 2003;21(3):272-80
references: 12743322
references: Br J Haematol. 1970 Mar;18(3):279-96
references: 5491581
references: Blood. 1994 Mar 1;83(5):1200-8
references: 8118024
references: Blood. 2003 Jan 1;101(1):124-33
references: 12393578
references: Annu Rev Biochem. 1998;67:753-91
references: 9759503
references: Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2626-31
references: 10716993
references: Stem Cells. 2004;22(4):457-74
references: 15277693
references: J Cell Sci. 2007 Mar 15;120(Pt 6):964-72
references: 17311849